The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
Posted by UE editors
Click to copy the Short Url to this post:
Upstract Is the Community for News Enthusiasts That Bring You the Whole Web on a Single Page. It Gets Even Better When You Join Us →